We just received data on a new analyst forecast for $ANNX. Jefferies gave a rating of 'Buy' for $ANNX.
$ANNX Analyst Ratings
Wall Street analysts have issued reports on $ANNX in the last several months. We have seen 5 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Jefferies issued a "Buy" rating on 05/13/2025
- Needham issued a "Buy" rating on 05/13/2025
- Barclays issued a "Overweight" rating on 05/13/2025
- Canaccord Genuity issued a "Buy" rating on 05/13/2025
- Benchmark issued a "Buy" rating on 05/13/2025
To track analyst ratings and price targets for $ANNX, check out Quiver Quantitative's $ANNX forecast page.
$ANNX Insider Trading Activity
$ANNX insiders have traded $ANNX stock on the open market 10 times in the past 6 months. Of those trades, 1 have been purchases and 9 have been sales.
Here’s a breakdown of recent trading of $ANNX stock by insiders over the last 6 months:
- TED YEDNOCK (EVP & CHIEF INNOVATION OFFICER) has made 0 purchases and 2 sales selling 10,128 shares for an estimated $29,615.
- JENNIFER LEW (EVP & CHIEF FINANCIAL OFFICER) has made 0 purchases and 2 sales selling 8,698 shares for an estimated $25,505.
- MICHAEL OVERDORF (EVP & CHIEF BUSINESS OFFICER) has made 0 purchases and 2 sales selling 8,043 shares for an estimated $23,783.
- WILLIAM H. CARSON purchased 3,200 shares for an estimated $17,056
- DEAN RICHARD ARTIS (EVP & CHIEF SCIENTIFIC OFFICER) sold 5,515 shares for an estimated $16,379
- JAMIE DANANBERG (CHIEF MEDICAL OFFICER) sold 5,521 shares for an estimated $16,342
- DOUGLAS LOVE (PRESIDENT AND CEO) sold 5,021 shares for an estimated $14,811
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$ANNX Hedge Fund Activity
We have seen 80 institutional investors add shares of $ANNX stock to their portfolio, and 72 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC removed 3,200,679 shares (-37.9%) from their portfolio in Q4 2024, for an estimated $16,419,483
- ADAGE CAPITAL PARTNERS GP, L.L.C. removed 2,840,145 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $14,569,943
- GMT CAPITAL CORP removed 1,908,366 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $9,789,917
- SPHERA FUNDS MANAGEMENT LTD. added 1,243,039 shares (+inf%) to their portfolio in Q4 2024, for an estimated $6,376,790
- EVENTIDE ASSET MANAGEMENT, LLC added 1,017,928 shares (+inf%) to their portfolio in Q4 2024, for an estimated $5,221,970
- FMR LLC removed 962,055 shares (-6.8%) from their portfolio in Q1 2025, for an estimated $1,856,766
- SIO CAPITAL MANAGEMENT, LLC added 933,852 shares (+65.2%) to their portfolio in Q4 2024, for an estimated $4,790,660
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
